Sanofi News - SAN

Best deals to access real time data!
Euronext
Monthly Subscription
for only
US$13.29
Euronext Level 2
Monthly Subscription
for only
US$29.55
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Sanofi SAN Euronext Ordinary Share FR0000120578
  Price Change Price Change % Stock Price High Price Low Price Open Price Close Price Last Trade
  0.86 1.16% 75.11 75.44 73.93 74.09 74.25 20:19:23
more quote information »

Recent News

Date Time Source Heading
7/15/201914:52GLOBESanofi : informations relatives au nombre total de droits de..
7/10/201919:05DJNSanofi: FDA to Review Isatuximab for Relapsed/Refractory..
7/10/201913:00GLOBESanofi : FDA to review isatuximab as a potential treatment..
7/03/201904:30GLOBESanofi : Mise en ligne du document «Pre-quarterly Results..
7/01/201922:00GLOBESanofi : Libtayo® (cemiplimab) approuvé dans l’Union..
6/28/201920:03DJNCommittee Recommends Approval for Dermatitis Treatment Be..
6/28/201919:00GLOBESanofi : CHMP recommends approval of Dupixent® (dupilumab)..
6/27/201913:00GLOBESanofi : La FDA va examiner le dossier du candidat-vaccin..
6/27/201902:30DJNFDA Approves Sanofi, Regeneron Treatment for Chronic..
6/27/201901:30GLOBESanofi : La FDA approuve Dupixent® (dupilumab) dans le..
6/21/201918:39DJNRegeneron, Sanofi Report Positive Topline Phase 2 Asthma..
6/21/201913:00GLOBESanofi et Regeneron annoncent les premiers résultats..
6/18/201913:44DJNSanofi, Google to Develop Healthcare Innovation Lab
6/18/201913:00GLOBESanofi et Google vont développer un nouveau laboratoire..
6/18/201901:17DJNVoyager Therapeutics Up 9%; Restructures Relationship with..
6/18/201900:28GLOBESanofi : informations relatives au nombre total de droits de..
6/17/201920:49DJNVoyager Therapeutics Restructures Gene Therapy Relationship..
6/10/201901:01GLOBESoliqua® Phase 3 results significantly lowered blood sugar..
6/10/201901:00ONELes résultats de phase III de Soliqua® montrent une baisse..
6/10/201901:00ONESoliqua® Phase 3 results significantly lowered blood sugar..
6/08/201902:48DJNSanofi on Track for Largest Percent Increase Since October..
6/07/201919:44DJNSanofi Shares Post Healthy Gains After New CEO News
6/07/201914:23DJNSanofi CEO Olivier Brandicourt Retires; Paul Hudson Named..
6/07/201913:50DJNSanofi Appoints New CEO
6/07/201913:01GLOBEPaul Hudson to succeed Olivier Brandicourt as Chief..
6/07/201913:00ONEPaul Hudson to succeed Olivier Brandicourt as Chief..
6/07/201913:00ONEPaul Hudson succèdera à Olivier Brandicourt comme Directeur..
6/07/201907:12DJNSanofi Poised to Appoint Novartis' Paul Hudson as Next CEO..
6/02/201922:46GLOBEPhase 3 trial of isatuximab combination therapy showed 40%..
6/02/201922:45ONEL'essai de phase III de l'isatuximab combiné au pomalidomide..
6/02/201922:45ONEPhase 3 trial of isatuximab combination therapy showed 40%..
5/22/201915:02DJNFrench Deal Spree Fueled By Easy Money -- WSJ
5/22/201902:23ONEInformation concerning the total number of voting rights and..
5/22/201902:23ONEInformations relatives au nombre total de droits de vote et..
5/21/201917:59DJNFrance Goes on Deal Spree, Thanks to ECB Easy Money
5/07/201921:39DJNEU Approves Sanofi and Regeneron's Dupixent for Severe..
5/07/201921:01GLOBESanofi : Dupixent® (dupilumab) Approved for Severe Asthma by..
5/07/201921:00ONESanofi : Dupixent® (dupilumab) Approved for Severe Asthma by..
5/07/201921:00ONESanofi : Dupixent® (dupilumab) approuvé dans le traitement..
5/02/201910:16DJNSanofi's Dengue Vaccine Gets FDA Approval -- Update
5/02/201907:38DJNFDA Approves Sanofi Inc.'s Dengue Vaccine
5/01/201900:01GLOBESanofi: Annual General Meeting of April 30, 2019
5/01/201900:00ONESanofi: Annual General Meeting of April 30, 2019
5/01/201900:00ONESanofi : Assemblée Générale Annuelle du 30 avril 2019
4/29/201923:40DJNLexicon Pharmaceuticals Up 7% After EU Approval for Diabetes..
4/29/201922:46DJNNegative Yields Deepen Along With Europe's Problems--Update
4/27/201908:29DJNFDA Approves Expanded Label for Praluent
4/27/201907:21GLOBESanofi: FDA approves Praluent® (alirocumab) to prevent heart..
4/27/201907:20ONESanofi: FDA approves Praluent® (alirocumab) to prevent heart..
4/27/201907:20ONESanofi : La FDA approuve Praluent® (alirocumab) dans la..
See more news about this stock »
Your Recent History
EU
SAN
Sanofi
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Finance Manila is owned and operated by ADVFN PLC.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190718 12:34:36